➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKinsey
Colorcon
Moodys
Express Scripts

Last Updated: July 31, 2021

DrugPatentWatch Database Preview

DOXYLAMINE SUCCINATE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Doxylamine Succinate, and when can generic versions of Doxylamine Succinate launch?

Doxylamine Succinate is a drug marketed by Copley Pharm, LNK, Perrigo, Quantum Pharmics, Actavis Labs Fl Inc, Mylan Pharms Inc, and Par Pharm Inc. and is included in seven NDAs.

The generic ingredient in DOXYLAMINE SUCCINATE is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.

Drug patent expirations by year for DOXYLAMINE SUCCINATE
Recent Clinical Trials for DOXYLAMINE SUCCINATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GrĂ¼nenthal, S.A.Phase 1
GrĂ¼nenthal GmbHPhase 1
Azidus BrasilPhase 3

See all DOXYLAMINE SUCCINATE clinical trials

Medical Subject Heading (MeSH) Categories for DOXYLAMINE SUCCINATE

US Patents and Regulatory Information for DOXYLAMINE SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Copley Pharm DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 088900-002 Feb 12, 1988 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Par Pharm Inc DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 208518-001 Dec 6, 2017 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Quantum Pharmics DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 088603-001 Aug 7, 1984 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Lnk DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 040564-001 Aug 27, 2004 OTC No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Perrigo DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 040167-001 Sep 18, 1996 OTC No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan Pharms Inc DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 207825-001 Jul 6, 2020 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Actavis Labs Fl Inc DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 205811-001 Aug 19, 2016 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKinsey
Colorcon
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.